Journal
ISCIENCE
Volume 24, Issue 2, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.isci.2021.102096
Keywords
-
Categories
Funding
- Australian National Health and Medical Research Council (NHMRC)
- AINSE Early Career Research Grant
- NHMRC CJ Martin Fellowship [1110429]
- Australian Research Council DECRA fellowship [DE210101479]
- NHMRC Senior Research Fellowship [1159272]
Ask authors/readers for more resources
Not all peptides derived from the internal SARS-CoV-2 nucleocapsid protein can form a complex with HLA-A*02:01, and some peptides adopt a mobile conformation. Limited pre-existing CD8+ T cell response toward these epitopes is observed in unexposed individuals.
CD8+ T cells are crucial for anti-viral immunity; however, understanding T cell responses requires the identification of epitopes presented by human leukocyte antigens (HLA). To date, few SARS-CoV-2-specific CD8+ T cell epitopes have been described. Internal viral proteins are typically more conserved than surface proteins and are often the target of CD8+ T cells. Therefore, we have characterized eight peptides derived from the internal SARS-CoV-2 nucleocapsid protein predicted to bind HLA-A*02:01, the most common HLA molecule in the global population. We determined not all peptides could forma complex with HLA-A*02:01, and the six crystal structures determined revealed that some peptides adopted a mobile conformation. We therefore provide a molecular understanding of SARSCoV-2 CD8+ T cell epitopes. Furthermore, we show that there is limited pre-existing CD8+ T cell response toward these epitopes in unexposed individuals. Together, these data show that SARS-CoV-2 nucleocapsid might not contain potent epitopes restricted to HLA-A*02:01.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available